Of mice and M&A: Horizon buys Sage Labs

The U.K.'s Horizon Discovery has snapped up St. Louis-based Sage Labs for $48 million in cash and stock. The deal delivers a leading developer of mouse models for preclinical drug R&D. The Cambridge-based biotech went public last March, raising £68.6 million as well as exciting fresh hopes for the U.K.'s life sciences field. Story